[Experience with in vitro rapid diagnostic methods (DHS-CLA) in childhood bronchial asthma]. 1991

E Kereki, and P Osváth, and A Szánthó, and E Kujalek
Szabadsághegyi Gyermekgyógyintézet, Budapest.

The authors examined the value of the chemoluminescent assay (CLA) in 35 asthmatic children. Each serum sample was examined concerning its reaction with 35 allergen extracts and the appropriate IgE value was also determined. The allergen-panel was adapted to the Hungarian prevalence. Results were read within 24 hours. Skin prick test and in vitro CLA results were in agreement in 89% of measurement. Purified, major antigens (grass, mite) gave a specially good concordance. Good agreement was also found in highly sensitized patients and children in the age below 3 years; in such cases RAST and CLA values were compared. In discordant cases revision of anamnesis supported the positive CLA result, however in some (5) negative CLA test this could not be strengthened. Chemoluminescent assay was shown to be fast, reliable and risk-free method, but high costs still limit its general use.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007428 Intradermal Tests Skin tests in which the sensitizer is injected. Passive Transfer Test,Prausnitz-Kustner Test,Intradermal Test,Passive Transfer Tests,Prausnitz Kustner Test,Test, Intradermal,Test, Passive Transfer,Test, Prausnitz-Kustner,Tests, Intradermal,Tests, Passive Transfer
D008163 Luminescent Measurements Techniques used for determining the values of photometric parameters of light resulting from LUMINESCENCE. Bioluminescence Measurements,Bioluminescent Assays,Bioluminescent Measurements,Chemiluminescence Measurements,Chemiluminescent Assays,Chemiluminescent Measurements,Chemoluminescence Measurements,Luminescence Measurements,Luminescent Assays,Luminescent Techniques,Phosphorescence Measurements,Phosphorescent Assays,Phosphorescent Measurements,Assay, Bioluminescent,Assay, Chemiluminescent,Assay, Luminescent,Assay, Phosphorescent,Assays, Bioluminescent,Assays, Chemiluminescent,Assays, Luminescent,Assays, Phosphorescent,Bioluminescence Measurement,Bioluminescent Assay,Bioluminescent Measurement,Chemiluminescence Measurement,Chemiluminescent Assay,Chemiluminescent Measurement,Chemoluminescence Measurement,Luminescence Measurement,Luminescent Assay,Luminescent Measurement,Luminescent Technique,Measurement, Bioluminescence,Measurement, Bioluminescent,Measurement, Chemiluminescence,Measurement, Chemiluminescent,Measurement, Chemoluminescence,Measurement, Luminescence,Measurement, Luminescent,Measurement, Phosphorescence,Measurement, Phosphorescent,Measurements, Bioluminescence,Measurements, Bioluminescent,Measurements, Chemiluminescence,Measurements, Chemiluminescent,Measurements, Chemoluminescence,Measurements, Luminescence,Measurements, Luminescent,Measurements, Phosphorescence,Measurements, Phosphorescent,Phosphorescence Measurement,Phosphorescent Assay,Phosphorescent Measurement,Technique, Luminescent,Techniques, Luminescent
D011852 Radioallergosorbent Test An in vitro allergen radioimmunoassay in which allergens are coupled to an immunosorbent. The coupled allergens bind the IgE in the sera of patients which in turn binds radioisotope-labeled anti-IMMUNOGLOBULIN E antibodies. Radioimmunosorbent Assay of Allergens,Allergens Radioimmunosorbent Assay,Allergens Radioimmunosorbent Assays,Radioallergosorbent Tests,Test, Radioallergosorbent,Tests, Radioallergosorbent
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

E Kereki, and P Osváth, and A Szánthó, and E Kujalek
August 1979, Polskie Archiwum Medycyny Wewnetrznej,
E Kereki, and P Osváth, and A Szánthó, and E Kujalek
August 1981, Minerva pediatrica,
E Kereki, and P Osváth, and A Szánthó, and E Kujalek
November 1950, Munchener medizinische Wochenschrift (1950),
E Kereki, and P Osváth, and A Szánthó, and E Kujalek
January 1965, GP,
E Kereki, and P Osváth, and A Szánthó, and E Kujalek
April 1986, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
E Kereki, and P Osváth, and A Szánthó, and E Kujalek
January 2002, Nihon rinsho. Japanese journal of clinical medicine,
E Kereki, and P Osváth, and A Szánthó, and E Kujalek
January 1994, Ryoikibetsu shokogun shirizu,
E Kereki, and P Osváth, and A Szánthó, and E Kujalek
January 1984, Ergebnisse der inneren Medizin und Kinderheilkunde,
E Kereki, and P Osváth, and A Szánthó, and E Kujalek
June 1997, Zeitschrift fur arztliche Fortbildung und Qualitatssicherung,
E Kereki, and P Osváth, and A Szánthó, and E Kujalek
January 1958, International archives of allergy and applied immunology,
Copied contents to your clipboard!